Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05947045 · ClinicalTrials.gov registry record · NA

Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors

A NA study of Brain Tumor, sponsored by St. Jude Children's Research Hospital.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT05947045: Recruiting NA study of Brain Tumor, sponsored by St. Jude Children's Research Hospital.

NCT05947045 is a NA study of Brain Tumor that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 45 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05947045, a NA study of Brain Tumor, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to estimate the feasibility and acceptability of cognitive training in the virtual reality setting with children undergoing radiotherapy for brain tumors. To achieve this goal, the investigators plan to study children undergoing radiotherapy for brain tumors randomly assigned to cognitive training administered via an iPad or virtual reality. Both groups will also participate in cognitive testing and exams using functional near infrared spectroscopy (fNIRS) pre- and post-intervention. The questions to be investigated are: 1. Will cognitive training via virtual reality be feasible and acceptable for children undergoing radiotherapy for brain tumors as indicated by participation rates, adherence and frequency of side effects? 2. Will cognitive training via virtual reality provide neurocognitive benefits? 3. Will there be predictable changes in brain activity as measured by neuroimaging? Findings from this study will be used to develop a larger, definitive trial with direct potential to improve cognitive outcomes for children treated for cancer using a safe and effective alternative to desktop- or laptop-based computerized cognitive interventions with great promise for improving quality of life.

Primary Outcome

The participation rate of this study (i.e., how many patients agree to participate/how many patients are approached for participation) and its 90% Blyth-Still-Casella exact binomial confidence intervals will be estimated for all participants.

Conditions Studied

Interventions

  • OTHER Cognitive training via iPad
  • OTHER Cognitive training via virtual reality

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2023-06-22
Est. Completion 2027-03
Phase NA

What NCT05947045 shows while recruiting

NCT05947045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 2 interventions - of which Cognitive training via iPad is the first listed.

NCT05947045 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT05947045 about?

NCT05947045 is a clinical study titled "Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors". The objective of this study is to estimate the feasibility and acceptability of cognitive training in the virtual reality setting with children undergoing radiotherapy for brain tumors. To achieve this goal, the investigators plan to study children undergoing radiotherapy for brain tumors randomly a...

What is the current status of trial NCT05947045?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2023-06-22. Estimated completion is 2027-03.

What conditions does trial NCT05947045 study?

This clinical trial studies the following conditions: Brain Tumor.

What interventions are being tested in trial NCT05947045?

The interventions under investigation include: Cognitive training via iPad (OTHER), Cognitive training via virtual reality (OTHER).

Who is sponsoring clinical trial NCT05947045?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05947045 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05947045's enrollment target sits among peer trials

45 34th of 69 higher than 36 of 69 other Brain Tumor trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05947045, the US trial registry maintained by the National Library of Medicine. NCT05947045 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.